Unlike previous reviews that have primarily concentrated on the canonical cGAS-DNA-STING axis or on the development of agonists in cancer immunotherapy [19,20], our work provides a comprehensive, system-level synthesis of both PRRs-dependent and PRRs-independent mechanisms of STING activation. Here, STING1 is linked to cancer.